A Possible Case of Hypertensive Crisis With Aortic Dissection After an Anti-COVID-19 Vaccine

被引:0
|
作者
Mohsenian, Leila [1 ,2 ]
Noroozi, Zahra [3 ]
Farahmand, Faramarz [1 ,2 ]
机构
[1] Shiraz Univ Med Sci, Namazi Teaching Hosp, Sch Med, Dept Emergency Med, Shiraz, Iran
[2] Shiraz Univ Med Sci, Emergency Med Res Ctr, Shiraz, Iran
[3] Shiraz Univ Med Sci, Shiraz, Iran
关键词
aneurysm; dissecting; aorta; effusion; pleural; vaccines; COVID-19; ANEURYSM;
D O I
10.1177/00033197241232619
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aortic dissection, a potentially fatal event, usually presents with acute intense chest or back pain. Painless aortic dissections constitute about 10% of all cases. High blood pressure is a common finding in both painless and painful aortic dissections. During the coronavirus disease (COVID-19) pandemic, various anti-COVID vaccines have been massively used. Although these vaccines are generally safe, there is a small risk of adverse effects which are mostly mild and transient, but sometimes they could be life-threatening. We report a case of painless aortic dissection that occurred within minutes of receiving the COVID-19 inactivated vaccine. A 65-year-old woman with chronic controlled systemic hypertension developed slurred speech, decreased level of consciousness, generalized weakness, and dyspnea without chest, back, or abdominal pain a few minutes after receiving the second dose of inactivated COVID-19 vaccine; she had a systolic blood pressure of 220 mmHg and left-sided pleural effusion. Drainage of the pleural effusion revealed gross blood and a spiral chest and mediastinum CT with intravenous contrast showed a penetrating atherosclerotic ulcer in the descending aorta. Therefore, thoracic endovascular aortic repair (TEVAR) was carried out, and the patient was discharged in satisfactory condition after 3 days.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] A Possible Case of Hypertensive Crisis With Intracranial Haemorrhage After an mRNA Anti-COVID-19 Vaccine
    Athyros, Vasilios G.
    Doumas, Michael
    ANGIOLOGY, 2022, 73 (01) : 87 - 87
  • [2] Lymphadenopathy after the Anti-COVID-19 Vaccine: Multiparametric Ultrasound Findings
    Cocco, Giulio
    Pizzi, Andrea Delli
    Fabiani, Stefano
    Cocco, Nino
    Boccatonda, Andrea
    Frisone, Alessio
    Scarano, Antonio
    Schiavone, Cosima
    BIOLOGY-BASEL, 2021, 10 (07):
  • [3] A severe case of rhabdomyolysis after Moderna mRNA anti-COVID-19 vaccine with a literature review
    Sheka, Maria
    Coattrenec, Yann
    Lorenzini, Kuntheavy Ing
    Nendaz, Mathieu
    CLINICAL CASE REPORTS, 2023, 11 (05):
  • [4] Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features
    Cocco, Giulio
    Delli Pizzi, Andrea
    Taraschi, Alessio Lino
    Boccatonda, Andrea
    Corvino, Antonio
    Ucciferri, Claudio
    Falasca, Katia
    Caulo, Massimo
    Vecchiet, Jacopo
    MEDICINA-LITHUANIA, 2022, 58 (02):
  • [5] Myositis Associated with the Anti-COVID-19 Covishield Vaccine
    Miqdadi, Amal
    Benmansour, Nouhad
    Herrag, Mohammed
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2023, 19 (01) : 77 - 78
  • [6] Principles and Challenges in anti-COVID-19 Vaccine Development
    Strizova, Zuzana
    Smetanova, Jitka
    Bartunkova, Jirina
    Milota, Tomas
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2021, 182 (04) : 339 - 349
  • [7] Hypertension after anti-COVID-19 vaccination
    Angeli, Fabio
    Reboldi, Gianpaolo
    Trapasso, Monica
    Verdecchia, Paolo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2022, 23 (01) : 10 - 14
  • [8] Cancer Patients' Attitudes Towards the Anti-Covid-19 Vaccine: A Collective Case Study
    Mirandola, Mara
    Andreis, Federica
    Deori, Chiara
    Kader, Sonia Abdel
    Wedenissow, Anna Chiara
    Malighetti, Clelia
    Meriggi, Fausto
    Zaniboni, Alberto
    REVIEWS ON RECENT CLINICAL TRIALS, 2024, 19 (01) : 62 - 69
  • [9] Urticarial vasculitis following mRNA anti-COVID-19 vaccine
    Nazzaro, Gianluca
    Maronese, Carlo Alberto
    DERMATOLOGIC THERAPY, 2022, 35 (03)
  • [10] Marposs supports the quality of anti-COVID-19 vaccine vials
    Bordini, Eleonora
    Glass International, 2021, 44 (04): : 39 - 40